IPO registrations (S-1, F-1) · Registrants
Cytosorbents Corp
- SEC CIK
- 1175151 · filings on EDGAR ↗
- Former names
- MedaSorb Technologies CORP (2006–2010); GILDER ENTERPRISES INC (2004–2006)
- Registration
- Form S-1, first filed 2008-12-12, last 2015-01-06; 6 initial registrations, 13 amendments
- Outcome
- Final prospectus filed 2010-07-02; declared effective 2010-06-15; withdrawal requested 2010-05-07
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 305 COLLEGE ROAD EAST, Princeton, NJ 08540
- EIN
- 98-0373793
- Ticker
- CTSO (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Cytosorbents Corp on the corporate pages
Offering terms
- Shares offered
- 24,653,846
- Listing
- OTC under the symbol CTSO
- Lead underwriters
- Table of
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: CYTOSORBENTS MEDICAL INC. EXACT (EIN (EXACT))
- Lobbying client: CYTOSORBENTS, INC. Fuzzy (name and state)
- SEC filer: Cytosorbents Corp EXACT (CIK (EXACT))
Filings 35
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2008-12-12 | S-1 | S-1 (registration) | MedaSorb Technologies CORP | 0001144204-08-068974 ↗ |
| 2009-06-22 | S-1/A | S-1/A (amendment) | MedaSorb Technologies CORP | 0001144204-09-033800 ↗ |
| 2010-05-07 | RW | RW (withdrawal request) | Cytosorbents Corp | 0001144204-10-025385 ↗ |
| 2010-06-04 | S-1 | S-1 (registration) | Cytosorbents Corp | 0001144204-10-032009 ↗ |
| 2010-06-15 | EFFECT | EFFECT (declared effective) | Cytosorbents Corp | 9999999995-10-001821 ↗ |
| 2010-07-02 | 424B1 | 424B1 (final prospectus) | Cytosorbents Corp | 0001144204-10-036263 ↗ |
| 2011-12-21 | S-1 | S-1 (registration) | Cytosorbents Corp | 0001144204-11-070847 ↗ |
| 2012-01-20 | S-1/A | S-1/A (amendment) | Cytosorbents Corp | 0001144204-12-003241 ↗ |
| 2012-02-06 | S-1/A | S-1/A (amendment) | Cytosorbents Corp | 0001144204-12-006027 ↗ |
| 2012-02-10 | EFFECT | EFFECT (declared effective) | Cytosorbents Corp | 9999999995-12-000458 ↗ |
| 2012-12-19 | EFFECT | EFFECT (declared effective) | Cytosorbents Corp | 9999999995-12-003575 ↗ |
| 2013-06-10 | EFFECT | EFFECT (declared effective) | Cytosorbents Corp | 9999999995-13-001747 ↗ |
| 2013-06-19 | S-1 | S-1 (registration) | Cytosorbents Corp | 0001144204-13-035632 ↗ |
| 2013-07-01 | EFFECT | EFFECT (declared effective) | Cytosorbents Corp | 9999999995-13-001974 ↗ |
| 2013-12-23 | S-1 | S-1 (registration) | Cytosorbents Corp | 0001144204-13-068711 ↗ |
| 2014-01-28 | S-1/A | S-1/A (amendment) | Cytosorbents Corp | 0001144204-14-004272 ↗ |
| 2014-02-10 | S-1/A | S-1/A (amendment) | Cytosorbents Corp | 0001144204-14-007186 ↗ |
| 2014-02-13 | S-1/A | S-1/A (amendment) | Cytosorbents Corp | 0001144204-14-008212 ↗ |
| 2014-02-14 | S-1/A | S-1/A (amendment) | Cytosorbents Corp | 0001144204-14-008884 ↗ |
| 2014-02-14 | EFFECT | EFFECT (declared effective) | Cytosorbents Corp | 9999999995-14-000472 ↗ |
| 2014-03-07 | S-1MEF | S-1MEF (added securities) | Cytosorbents Corp | 0001144204-14-014036 ↗ |
| 2014-03-07 | 424B4 | 424B4 (final prospectus) | Cytosorbents Corp | 0001144204-14-014055 ↗ |
| 2014-06-30 | EFFECT | EFFECT (declared effective) | Cytosorbents Corp | 9999999995-14-001976 ↗ |
| 2014-10-31 | S-1 | S-1 (registration) | Cytosorbents Corp | 0001144204-14-064421 ↗ |
| 2014-11-13 | S-1/A | S-1/A (amendment) | Cytosorbents Corp | 0001144204-14-067357 ↗ |
| 2014-12-08 | S-1/A | S-1/A (amendment) | Cytosorbents Corp | 0001144204-14-072673 ↗ |
| 2014-12-12 | S-1/A | S-1/A (amendment) | Cytosorbents Corp | 0001144204-14-073706 ↗ |
| 2014-12-16 | S-1/A | S-1/A (amendment) | Cytosorbents Corp | 0001144204-14-074159 ↗ |
| 2014-12-30 | S-1/A | S-1/A (amendment) | Cytosorbents Corp | 0001144204-14-076436 ↗ |
| 2015-01-06 | S-1/A | S-1/A (amendment) | Cytosorbents Corp | 0001144204-15-000772 ↗ |
| 2015-01-08 | EFFECT | EFFECT (declared effective) | Cytosorbents Corp | 9999999995-15-000052 ↗ |
| 2015-01-09 | 424B1 | 424B1 (final prospectus) | Cytosorbents Corp | 0001144204-15-001485 ↗ |
| 2015-07-29 | EFFECT | EFFECT (declared effective) | Cytosorbents Corp | 9999999995-15-002103 ↗ |
| 2015-10-20 | EFFECT | EFFECT (declared effective) | Cytosorbents Corp | 9999999995-15-002803 ↗ |
| 2015-10-20 | EFFECT | EFFECT (declared effective) | Cytosorbents Corp | 9999999995-15-002804 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2010-06-04 | S-1 | registration statement | 24,653,846 | - | OTC CTSO | 0 | primary document; shares headline | document ↗ | ||
| 2010-07-02 | 424B1 | final prospectus | 24,653,846 | - | OTC CTSO | 1 | primary document; shares headline, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BOWES JOSEPH G | Director,Officer,TenPercentOwner | President, Secretary, CEO, CFO | 1 | 2006 | |
| Capponi Vincent | Director,Officer; Officer; OfficerOther | Chief Operating Officer; President; President and COO; President & COO; See Remarks | 51 | 2006–2026 | |
| CHASSMAN MARGIE | TenPercentOwner | 2 | 2006 | ||
| Katz Kurt | Director | 4 | 2006–2008 | ||
| Kraus Al | Director; Director,Officer | CEO and President; President & CEO | 74 | 2006–2023 | |
| Lamadrid David | Officer | Chief Financial Officer | 11 | 2006–2011 | |
| Rubin Joseph | Director | 12 | 2006–2014 | ||
| Winchester James F | Officer | Chief Medical Officer | 5 | 2006–2008 | |
| Montiel Guillermina | TenPercentOwner | 1 | 2006 | ||
| MILLER WILLIAM R | Director | 4 | 2007–2008 | ||
| Jones Edward Raymond | Director | 25 | 2007–2025 | ||
| Whalen Martin F | Director | 2 | 2007–2008 | ||
| Chan Phillip P. | Director; Director,Officer; Officer | CEO and President; CEO & President; Chief Executive Officer; Interim CEO; Interim Chief Executive Office; President and CEO | 55 | 2008–2026 | |
| Gunton James T. | Director; Director,TenPercentOwner | 14 | 2008–2015 | ||
| BARTLETT ROBERT HAWES | Officer | Chief Medical Officer | 7 | 2009–2017 | |
| Bocchino Thomas | Officer | Chief Financial Officer | 1 | 2012 | |
| BERGER RONALD | Officer | Interim CFO; See Remarks | 2 | 2013 | |
| BLOCH KATHLEEN P. | Officer | Chief Financial Officer; Interim CFO | 46 | 2013–2024 | |
| Shipley Robert | TenPercentOwner | 1 | 2015 | ||
| Sobel Alan D. | Director | 19 | 2015–2026 | ||
| BATOR MICHAEL G. | Director | 19 | 2015–2025 | ||
| NJTC INVESTMENT FUND, LP | TenPercentOwner | 2 | 2016 | ||
| Mortensen Eric R. | Officer | Chief Medical Officer | 8 | 2017–2019 | |
| Deliargyris Efthymios | Officer | Chief Medical Officer | 11 | 2020–2025 | |
| Kim Jiny | Director | 8 | 2022–2025 | ||
| D'Amico Alex | Officer | Chief Financial Officer | 1 | 2023 | |
| MARIANI PETER J | Officer | Chief Financial Officer | 8 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | CYTOSORBENTS MEDICAL INC. | NJ | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Lobbying client | CYTOSORBENTS, INC. | NJ | Federal lobbying (LDA) | name and state |
| Patent assignee | CytoSorbents, Inc. | NJ | Patents (USPTO) | name and state |
| SEC filer | Cytosorbents Corp | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | CYTOSORBENTS CORPORATION | NJ | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | CYTOSORBENTS MEDICAL INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, NJ first:
- ANTARES PHARMA, INC. NJ
- INTERPACE BIOSCIENCES, INC. NJ
- NEPHROS INC NJ
- NUCRYST Pharmaceuticals Corp. NJ
- BAETA CORP NJ
- VALERITAS INC NJ
- Glucotrack, Inc. NJ
- Turnpoint Medical Devices, Inc. NJ
- Valeritas Holdings Inc. NJ
- CHP Merger Corp. NJ
In other datasets, the same topic (Technology) in NJ:
- Form D issuer: A2Zlogix, Inc. (Form D private offerings)
- Lobbying client: 1KOSMOS INC (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology